HEADER TRANSCRIPTION 14-OCT-09 3K8S TITLE CRYSTAL STRUCTURE OF PPARG IN COMPLEX WITH T2384 COMPND MOL_ID: 1; COMPND 2 MOLECULE: PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: UNP RESIDUES 234-505, LIGAND BINDING DOMAIN; COMPND 5 SYNONYM: PPAR-GAMMA, NUCLEAR RECEPTOR SUBFAMILY 1 GROUP C COMPND 6 MEMBER 3; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PPARG, NR1C3; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET30 KEYWDS PPARGAMMA, LIGAND BINDING POCKET, LIGAND, DIABETIC, KEYWDS 2 ACTIVATOR, ALTERNATIVE SPLICING, DIABETES MELLITUS, DISEASE KEYWDS 3 MUTATION, DNA-BINDING, METAL-BINDING, NUCLEUS, OBESITY, KEYWDS 4 PHOSPHOPROTEIN, POLYMORPHISM, RECEPTOR, TRANSCRIPTION, KEYWDS 5 TRANSCRIPTION REGULATION, ZINC, ZINC-FINGER, LBD AND LIGAND KEYWDS 6 BINDING DOMAIN EXPDTA X-RAY DIFFRACTION AUTHOR Z.WANG REVDAT 1 03-NOV-09 3K8S 0 JRNL AUTH Y.LI,Z.WANG,N.FURUKAWA,P.ESCARON,J.WEISZMANN,G.LEE, JRNL AUTH 2 M.LINDSTROM,J.LIU,X.LIU,H.XU,O.PLOTNIKOVA,V.PRASAD, JRNL AUTH 3 N.WALKER,R.M.LEARNED,J.-L.CHEN JRNL TITL T2384, A NOVEL ANTIDIABETIC AGENT WITH UNIQUE JRNL TITL 2 PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA JRNL TITL 3 BINDING PROPERTIES JRNL REF J.BIOL.CHEM. V. 283 9168 2008 JRNL REFN ISSN 0021-9258 JRNL PMID 18263587 JRNL DOI 10.1074/JBC.M800104200 REMARK 1 REMARK 2 REMARK 2 RESOLUTION. 2.55 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES, PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.55 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 40.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 22667 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING SET) : 0.226 REMARK 3 FREE R VALUE : 0.273 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4182 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 99 REMARK 3 SOLVENT ATOMS : 15 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : NULL REMARK 3 BOND ANGLES (DEGREES) : NULL REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3K8S COMPLIES WITH FORMAT V. 3.20, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 20-OCT-09. REMARK 100 THE RCSB ID CODE IS RCSB055689. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 26-JAN-01 REMARK 200 TEMPERATURE (KELVIN) : NULL REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 5.0.2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : NULL REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : NULL REMARK 200 DETECTOR MANUFACTURER : NULL REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 22667 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.500 REMARK 200 RESOLUTION RANGE LOW (A) : 40.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : NULL REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PDB ENTRY 2PRG REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 53.85 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.67 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NULL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 45.77650 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 31.19800 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 45.77650 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 31.19800 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 PRO A 206 REMARK 465 GLU A 272 REMARK 465 GLN A 273 REMARK 465 SER A 274 REMARK 465 LYS A 275 REMARK 465 THR A 461 REMARK 465 ASP A 462 REMARK 465 MET A 463 REMARK 465 SER A 464 REMARK 465 TYR A 477 REMARK 465 PRO B 206 REMARK 465 ILE B 262 REMARK 465 LYS B 263 REMARK 465 PHE B 264 REMARK 465 LYS B 265 REMARK 465 HIS B 266 REMARK 465 ILE B 267 REMARK 465 THR B 268 REMARK 465 PRO B 269 REMARK 465 LEU B 270 REMARK 465 GLN B 271 REMARK 465 GLU B 272 REMARK 465 GLN B 273 REMARK 465 SER B 274 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 MET A 257 -82.87 -59.69 REMARK 500 PRO A 269 176.19 -57.99 REMARK 500 PHE A 347 103.83 -160.31 REMARK 500 THR A 459 72.92 -103.14 REMARK 500 ASP A 475 -80.82 -137.43 REMARK 500 THR B 238 -81.85 -84.67 REMARK 500 THR B 241 -171.04 41.29 REMARK 500 THR B 242 -71.51 71.15 REMARK 500 GLU B 259 35.09 -82.17 REMARK 500 PHE B 347 115.21 -160.90 REMARK 500 PRO B 426 -8.02 -55.98 REMARK 500 SER B 464 114.42 64.00 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE Z27 A 1 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE Z27 B 2 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE Z27 B 1 DBREF 3K8S A 206 477 UNP P37231 PPARG_HUMAN 234 505 DBREF 3K8S B 206 477 UNP P37231 PPARG_HUMAN 234 505 SEQRES 1 A 272 PRO GLU SER ALA ASP LEU ARG ALA LEU ALA LYS HIS LEU SEQRES 2 A 272 TYR ASP SER TYR ILE LYS SER PHE PRO LEU THR LYS ALA SEQRES 3 A 272 LYS ALA ARG ALA ILE LEU THR GLY LYS THR THR ASP LYS SEQRES 4 A 272 SER PRO PHE VAL ILE TYR ASP MET ASN SER LEU MET MET SEQRES 5 A 272 GLY GLU ASP LYS ILE LYS PHE LYS HIS ILE THR PRO LEU SEQRES 6 A 272 GLN GLU GLN SER LYS GLU VAL ALA ILE ARG ILE PHE GLN SEQRES 7 A 272 GLY CYS GLN PHE ARG SER VAL GLU ALA VAL GLN GLU ILE SEQRES 8 A 272 THR GLU TYR ALA LYS SER ILE PRO GLY PHE VAL ASN LEU SEQRES 9 A 272 ASP LEU ASN ASP GLN VAL THR LEU LEU LYS TYR GLY VAL SEQRES 10 A 272 HIS GLU ILE ILE TYR THR MET LEU ALA SER LEU MET ASN SEQRES 11 A 272 LYS ASP GLY VAL LEU ILE SER GLU GLY GLN GLY PHE MET SEQRES 12 A 272 THR ARG GLU PHE LEU LYS SER LEU ARG LYS PRO PHE GLY SEQRES 13 A 272 ASP PHE MET GLU PRO LYS PHE GLU PHE ALA VAL LYS PHE SEQRES 14 A 272 ASN ALA LEU GLU LEU ASP ASP SER ASP LEU ALA ILE PHE SEQRES 15 A 272 ILE ALA VAL ILE ILE LEU SER GLY ASP ARG PRO GLY LEU SEQRES 16 A 272 LEU ASN VAL LYS PRO ILE GLU ASP ILE GLN ASP ASN LEU SEQRES 17 A 272 LEU GLN ALA LEU GLU LEU GLN LEU LYS LEU ASN HIS PRO SEQRES 18 A 272 GLU SER SER GLN LEU PHE ALA LYS LEU LEU GLN LYS MET SEQRES 19 A 272 THR ASP LEU ARG GLN ILE VAL THR GLU HIS VAL GLN LEU SEQRES 20 A 272 LEU GLN VAL ILE LYS LYS THR GLU THR ASP MET SER LEU SEQRES 21 A 272 HIS PRO LEU LEU GLN GLU ILE TYR LYS ASP LEU TYR SEQRES 1 B 272 PRO GLU SER ALA ASP LEU ARG ALA LEU ALA LYS HIS LEU SEQRES 2 B 272 TYR ASP SER TYR ILE LYS SER PHE PRO LEU THR LYS ALA SEQRES 3 B 272 LYS ALA ARG ALA ILE LEU THR GLY LYS THR THR ASP LYS SEQRES 4 B 272 SER PRO PHE VAL ILE TYR ASP MET ASN SER LEU MET MET SEQRES 5 B 272 GLY GLU ASP LYS ILE LYS PHE LYS HIS ILE THR PRO LEU SEQRES 6 B 272 GLN GLU GLN SER LYS GLU VAL ALA ILE ARG ILE PHE GLN SEQRES 7 B 272 GLY CYS GLN PHE ARG SER VAL GLU ALA VAL GLN GLU ILE SEQRES 8 B 272 THR GLU TYR ALA LYS SER ILE PRO GLY PHE VAL ASN LEU SEQRES 9 B 272 ASP LEU ASN ASP GLN VAL THR LEU LEU LYS TYR GLY VAL SEQRES 10 B 272 HIS GLU ILE ILE TYR THR MET LEU ALA SER LEU MET ASN SEQRES 11 B 272 LYS ASP GLY VAL LEU ILE SER GLU GLY GLN GLY PHE MET SEQRES 12 B 272 THR ARG GLU PHE LEU LYS SER LEU ARG LYS PRO PHE GLY SEQRES 13 B 272 ASP PHE MET GLU PRO LYS PHE GLU PHE ALA VAL LYS PHE SEQRES 14 B 272 ASN ALA LEU GLU LEU ASP ASP SER ASP LEU ALA ILE PHE SEQRES 15 B 272 ILE ALA VAL ILE ILE LEU SER GLY ASP ARG PRO GLY LEU SEQRES 16 B 272 LEU ASN VAL LYS PRO ILE GLU ASP ILE GLN ASP ASN LEU SEQRES 17 B 272 LEU GLN ALA LEU GLU LEU GLN LEU LYS LEU ASN HIS PRO SEQRES 18 B 272 GLU SER SER GLN LEU PHE ALA LYS LEU LEU GLN LYS MET SEQRES 19 B 272 THR ASP LEU ARG GLN ILE VAL THR GLU HIS VAL GLN LEU SEQRES 20 B 272 LEU GLN VAL ILE LYS LYS THR GLU THR ASP MET SER LEU SEQRES 21 B 272 HIS PRO LEU LEU GLN GLU ILE TYR LYS ASP LEU TYR HET Z27 A 1 33 HET Z27 B 2 33 HET Z27 B 1 33 HETNAM Z27 2-CHLORO-N-{3-CHLORO-4-[(5-CHLORO-1,3-BENZOTHIAZOL-2- HETNAM 2 Z27 YL)SULFANYL]PHENYL}-4-(TRIFLUOROMETHYL) HETNAM 3 Z27 BENZENESULFONAMIDE FORMUL 3 Z27 3(C20 H10 CL3 F3 N2 O2 S3) FORMUL 6 HOH *15(H2 O) HELIX 1 1 GLU A 207 PHE A 226 1 20 HELIX 2 2 THR A 229 GLY A 239 1 11 HELIX 3 3 ASP A 251 LYS A 263 1 13 HELIX 4 4 GLU A 276 SER A 302 1 27 HELIX 5 5 ASP A 310 ALA A 331 1 22 HELIX 6 6 SER A 342 GLY A 344 5 3 HELIX 7 7 ARG A 350 LEU A 356 1 7 HELIX 8 8 PRO A 359 PHE A 363 5 5 HELIX 9 9 MET A 364 LEU A 377 1 14 HELIX 10 10 ASP A 380 LEU A 393 1 14 HELIX 11 11 ASN A 402 HIS A 425 1 24 HELIX 12 12 GLN A 430 THR A 459 1 30 HELIX 13 13 HIS A 466 TYR A 473 1 8 HELIX 14 14 GLU B 207 PHE B 226 1 20 HELIX 15 15 THR B 229 GLY B 239 1 11 HELIX 16 16 ASP B 251 GLY B 258 1 8 HELIX 17 17 GLU B 276 LYS B 301 1 26 HELIX 18 18 ASP B 310 SER B 332 1 23 HELIX 19 19 SER B 342 GLY B 344 5 3 HELIX 20 20 ARG B 350 LEU B 356 1 7 HELIX 21 21 PRO B 359 PHE B 363 5 5 HELIX 22 22 MET B 364 ALA B 376 1 13 HELIX 23 23 ASP B 380 LEU B 393 1 14 HELIX 24 24 ASN B 402 HIS B 425 1 24 HELIX 25 25 GLN B 430 GLN B 437 1 8 HELIX 26 26 LYS B 438 GLU B 460 1 23 HELIX 27 27 HIS B 466 TYR B 473 1 8 SHEET 1 A 4 PHE A 247 ILE A 249 0 SHEET 2 A 4 GLY A 346 THR A 349 1 O PHE A 347 N ILE A 249 SHEET 3 A 4 GLY A 338 ILE A 341 -1 N ILE A 341 O GLY A 346 SHEET 4 A 4 MET A 334 ASN A 335 -1 N ASN A 335 O GLY A 338 SHEET 1 B 4 PHE B 247 ILE B 249 0 SHEET 2 B 4 GLY B 346 THR B 349 1 O PHE B 347 N ILE B 249 SHEET 3 B 4 GLY B 338 ILE B 341 -1 N ILE B 341 O GLY B 346 SHEET 4 B 4 MET B 334 ASN B 335 -1 N ASN B 335 O GLY B 338 CISPEP 1 LYS A 358 PRO A 359 0 -0.35 CISPEP 2 LYS B 358 PRO B 359 0 2.47 SITE 1 AC1 16 ILE A 262 PHE A 264 ILE A 267 PHE A 282 SITE 2 AC1 16 CYS A 285 GLN A 286 ARG A 288 SER A 289 SITE 3 AC1 16 TYR A 327 LEU A 330 SER A 342 LEU A 356 SITE 4 AC1 16 PHE A 360 MET A 364 LYS A 367 HIS A 449 SITE 1 AC2 13 Z27 B 1 GLU B 259 ARG B 280 ILE B 281 SITE 2 AC2 13 GLY B 284 CYS B 285 ARG B 288 VAL B 339 SITE 3 AC2 13 ILE B 341 SER B 342 MET B 348 LEU B 353 SITE 4 AC2 13 MET B 364 SITE 1 AC3 18 Z27 B 2 LEU B 228 ALA B 278 ILE B 281 SITE 2 AC3 18 PHE B 282 CYS B 285 GLN B 286 ARG B 288 SITE 3 AC3 18 SER B 289 ILE B 326 TYR B 327 LEU B 330 SITE 4 AC3 18 LEU B 333 LEU B 356 PHE B 360 MET B 364 SITE 5 AC3 18 LYS B 367 HIS B 449 CRYST1 91.553 62.396 118.943 90.00 102.63 90.00 C 1 2 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010923 0.000000 0.002448 0.00000 SCALE2 0.000000 0.016027 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008616 0.00000 MASTER 295 0 3 27 8 0 13 6 0 0 0 42 END